Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P991 | DOI: 10.1530/endoabs.110.P991

1Columbia University, New York, United States; 2Justus Liebig University, Giessen, Germany; 3Keck School of Medicine, Los Angeles, United States; 4Lunenfeld-Tanenbaum Research Institute, Toronto, Canada; 5University of Pennsylvania, Philadelphia, United States; 6University of Utah, Utah, United States; 7Fox Chase Cancer Center, Philadelphia, United States; 8Stanford University, Stanford, United States; 9Boston Children’s Hospital, Boston, United States; 10Barnard University, New York, United States


JOINT1739

Background: There are ongoing concerns about declining age of puberty in females and what is driving the decline. We aimed to identify patterns in the hormonal steroid metabolome associated with accelerated pubertal development in girls, and to determine if this association was modified by body mass index (BMI), markers of stress, and breast cancer family history.

Methods: In the LEGACY Girls Study, we measured 36 metabolites of glucocorticoids, androgens, progesterone, and estrogens in two urine specimens collected before (pre, n = 327) and during puberty (pubertal, n = 115). Parents assessed the age at breast development (thelarche) through the Pubertal Development Scale. Girls aged ≥10 years self-reported age at menarche. Study staff measured participants’ height and weight and administered the Internalizing Composite Scale (a parent proxy of child stress). We estimated hazard ratios (HR) and 95% confidence intervals (CI) for the association between a doubling in steroid metabolites (μg/mL per mg of creatinine) and age at thelarche, pubarche and menarche using Weibull survival models, testing for interactions with stress BMI z-scores, and family history using cross-product terms. We also used 12 principal components of pre-pubertal steroid metabolite data as predictors in Weibull models.

Results: Higher pre-pubertal levels of urinary metabolites of glucocorticoids (HR=1.9, 95% CI 1.5-2.5), androgens (HR=3.9, 95%CI 2.7-5.6) and progesterone (HR=6.7, 95%CI 4.1-10.9) were associated with accelerated thelarche. Higher pre-pubertal (HR=0.2, 95%CI 0.1-0.5) and pubertal (HR=0.4, 95%CI 0.2-0.9) levels of estrogen metabolites were associated with delayed menarche. Higher levels of pubertal androgen (HR=0.3, 95%CI 0.1-0.8) and progesterone (HR=0.2, 95%CI 0.07-0.7) metabolites were associated with longer pubertal tempo. Girls with high glucocorticoid metabolites, BMI (≥15.6 kg/m2) and stress (≥ 46) reached thelarche 7 months earlier than girls with low glucocorticoid metabolites, BMI (<15.6 kg/m2) and stress (<46). There were no interactions with family history. There were 12 primary principal components that explained 95% of the variation in the steroid metabolites and 3 of these were significantly associated with earlier age at thelarche including scores either high glucocorticoids, or high in androgen and progesterone metabolites and low levels of glucocorticoid metabolites, or high progesterone metabolites, specifically high 17a-hydroxypregnanolone, pregnenediol, but low 11-oxo-androsterone.

Conclusion: Elevated metabolites of glucocorticoids, androgens and progesterone are associated with accelerated pubertal onset, and BMI and stress modify this association. Previous studies focus on estrogens, menarche and BMI; our results suggest that androgens and stress impact age at thelarche with implications for our understanding of pubertal development.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches